NASDAQ: NUVLNuvalent Inc Stock Ownership - Who owns Nuvalent?
Insider buying vs selling
Have Nuvalent Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Matthew Shair | Director | 2024-04-22 | 14,650 | $64.52 | $945.22kSell |
| Matthew Shair | Director | 2024-04-22 | 14,156 | $62.66 | $887.01kSell |
| Matthew Shair | Director | 2024-04-22 | 8,694 | $63.80 | $554.68kSell |
| Emily Conley | Director | 2024-04-15 | 6 | $66.66 | $399.96Sell |
| Emily Conley | Director | 2024-04-15 | 4,994 | $65.52 | $327.21kSell |
| Emily Conley | Director | 2024-04-15 | 5,000 | $9.36 | $46.80kBuy |
| Matthew Shair | Director | 2024-04-15 | 11,900 | $66.17 | $787.42kSell |
| Matthew Shair | Director | 2024-04-15 | 25,600 | $65.27 | $1.67MSell |
| Matthew Shair | Director | 2024-04-08 | 1,000 | $69.64 | $69.64kSell |
| Matthew Shair | Director | 2024-04-08 | 25,478 | $68.63 | $1.75MSell |
NUVL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NUVL insiders and whales buy or sell their stock.
NUVL Shareholders
What type of owners hold Nuvalent Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James E. Flynn | 31.20% | 19,991,024 | $1.34B | Insider |
| Deerfield Management Company LP Series C | 31.20% | 19,991,024 | $1.34B | Institution |
| Fmr LLC | 13.62% | 8,725,070 | $583.36M | Institution |
| Paradigm Biocapital Advisors LP | 6.02% | 3,858,008 | $257.95M | Institution |
| Bain Capital Life Sciences Investors LLC | 5.58% | 3,577,267 | $239.18M | Institution |
| Vanguard Group Inc | 5.21% | 3,339,850 | $223.30M | Institution |
| Perceptive Advisors LLC | 4.55% | 2,917,991 | $195.10M | Institution |
| Blackrock Inc | 4.25% | 2,721,195 | $181.94M | Institution |
| Andrew A. F. Hack | 4.21% | 2,697,267 | $180.34M | Insider |
| Fairmount Funds Management LLC | 3.00% | 1,924,626 | $128.68M | Institution |
NUVL vs Biotech Stocks
Nuvalent Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.